Genetic perspective of retinoblastoma: From present to future
- PMID: 27380971
- PMCID: PMC4966369
- DOI: 10.4103/0301-4738.185585
Genetic perspective of retinoblastoma: From present to future
Abstract
Retinoblastoma (RB) is the most common malignant intraocular tumor in children. In the last decade, basic research has led to a better understanding of events after two hits in RB susceptibility gene (RB1), molecular mechanism of tumor growth, the cell of origin of RB, etc. This would pave way to identify biomarkers and molecular targeted therapy for better treatment option in the future. Furthermore, improvement in molecular techniques has led to enhanced diagnostic methods for early diagnosis, genetic counseling, and prevention of the disease. This review will help to understand the essence of basic research work conducted in recent times and its implication in the management of RB in the future.
Figures
References
-
- Bishop JO, Madson EC. Retinoblastoma. Review of the current status. Surv Ophthalmol. 1975;19:342–66. - PubMed
-
- Shields JA, Shields CL. Intraocular Tumors – A Text and Atlas. Philadelphia, PA, USA: WB Saunders Company; 1992.
-
- Shanmugam MP, Biswas J, Gopal L, Sharma T, Nizamuddin SH. The clinical spectrum and treatment outcome of retinoblastoma in Indian children. J Pediatr Ophthalmol Strabismus. 2005;42:75–81. - PubMed
-
- Albert DM. Historic review of retinoblastoma. Ophthalmology. 1987;94:654–62. - PubMed
-
- Chan HS, Gallie BL, Munier FL, Beck Popovic M. Chemotherapy for retinoblastoma. Ophthalmol Clin North Am. 2005;18:55–63. viii. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
